A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDS - Contacts and Locations

A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDS

This study has been completed.

Study NCT00002034. Last updated on June 23, 2005. Information provided by NIH AIDS Clinical Trials Information Service

Please refer to this study by its ClinicalTrials.gov identifier: NCT00002034

Locations


United States, Alabama
	Univ of Alabama at Birmingham
	Birmingham, Alabama, United States, 35294

United States, California
	Stanford at Kaiser / Kaiser Permanente Med Ctr
	San Francisco, California, United States, 94115
	Summitt Med Ctr / San Francisco Gen Hosp
	Oakland, California, United States, 94609

United States, Florida
	Miami Veterans Administration Med Ctr
	Miami, Florida, United States, 33125

United States, Georgia
	Dr Winkler Weinberg
	Roswell, Georgia, United States, 30076

United States, New York
	SUNY / Health Sciences Ctr at Stony Brook
	Stony Brook, New York, United States, 117948153

United States, South Carolina
	Dr Alfred F Burnside Jr
	Columbia, South Carolina, United States, 29204

United States, Texas
	Univ TX Galveston Med Branch
	Galveston, Texas, United States, 77550

Canada, Alberta
	Southern Alberta HIV Clinic / Foothills Hosp
	Calgary, Alberta, Canada

Sponsors and Collaborators

Hoffmann-La Roche